Carregant...
Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers
Immune checkpoint inhibition has transformed cancer treatment. For gastroesophageal cancer, this class of drugs have demonstrated durable responses and survival benefit in a subgroup of patients, resulting in regulatory approval. However, several recent randomized phase III studies in gastroesophage...
Guardat en:
| Publicat a: | Front Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243739/ https://ncbi.nlm.nih.gov/pubmed/32500029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00763 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|